🔴 Heron Therapeutics is trading 8.01% down today with no new company-specific catalyst identified

Heron Therapeutics is trading 8.01% down at $0.28, with no clear company-specific announcement identified for September 21, 2026.

• Recent reporting points to previously disclosed CINVANTI patent uncertainty, withdrawn 2026 guidance, and strategic-review concerns—not a new catalyst on this date.
• The broader market is rising, so the decline does not appear driven by overall risk sentiment.
• Reuters showed the prior session at $0.31, down 1.90%.